Johannes Stein

The Immune Checkpoint Regulator PD-L1 Is Highly Expressed in Aggressive Primary Prostate Cancer

Heidrun Gevensleben, Dimo Dietrich, Carsten Golletz et al. · Clinical Cancer Research · 2015 · 234 citations

Medicine, Oncology, Pathology +17

KDM5C Is Overexpressed in Prostate Cancer and Is a Prognostic Marker for Prostate-Specific Antigen-Relapse Following Radical Prostatectomy

Johannes Stein, Michael Majores, Magdalena Rohde et al. · American Journal Of Pathology · 2014 · 78 citations · Full text

Medicine, Oncology, Urology +14

<i>CDO1</i> promoter methylation is associated with gene silencing and is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients

Sebastian Meller, Lisa Zipfel, Heidrun Gevensleben et al. · Epigenetics · 2016 · 49 citations · Full text

Medicine, Molecular Biology, Oncology +17

PITX2 DNA Methylation as Biomarker for Individualized Risk Assessment of Prostate Cancer in Core Biopsies

Barbara Uhl, Heidrun Gevensleben, Yuri Tolkach et al. · Journal of Molecular Diagnostics · 2016 · 48 citations

Medicine, Oncology, Urology +17

Membranous CD24 expression as detected by the monoclonal antibody SWA11 is a prognostic marker in non-small cell lung cancer patients

Michael Majores, A. F. Schindler, Ângela Fuchs et al. · BMC Clinical Pathology · 2015 · 24 citations · Full text

Medicine, Oncology, Pathology +17